1. Troyer G, Schenter R (2009) Medical isotope development and supply opportunities in the 21st century. J Radioanal Nucl Chem 282:243–246. doi: 10.1007/s10967-009-0267-4
2. Yousefnia H, Jalilian AR, Zolghadri S, Bahrami-Samani A, Shirvani-Arani S, Ghannadi-Maragheh M (2010) Preparation and quality control of lutetium-177 bleomycin as a possible therapeutic agent. Nukleonika 55:285–291
3. Naseri Z, Hakimi A, Jalilian A, Nemati Kharat A, Shirvani-Arani S, Bahrami-Samani A, Ghannadi-Maragheh M (2012) Synthesis, quality control and biological evaluation of tris [(1, 10-phenanthroline)[153Sm] samarium(III)] trithiocyanate complex as a therapeutic agent. Radiochim Acta Int J Chem Asp Nucl Sci Technol 100:267–271. doi: 10.1524/ract.2012.1910
4. Firestone RB, Shirley VS, Baglin CM, Zipkin J (1996) In: Table of isotopes. Wiley, New York, p 1447
5. Chakraborty S, Das T, Sarma HD, Venkatesh M, Banerjee S (2008) Comparative studies of 177 Lu–EDTMP and 177 Lu–DOTMP as potential agents for palliative radiotherapy of bone metastasis. Appl Radiat Isot 66:1196–1205. doi: 10.1016/j.apradiso.2008.02.061